At a glance
ClinicalIndex Comparison RecordN/ACompleted· 273 enrolled / 273 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·observational·Posted Nov 4, 1999·Updated Jun 30, 2026
In Brief
An observational study for Zollinger Ellison Syndrome. Completed, enrolled 273 participants across 1 site.
Detailed Summary
This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsZollinger Ellison Syndrome
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 1991
First PostedNov 1999
TodayJul 2026
First PostedNov 4, 1999
Enrollment StartOct 29, 1991
TodayJul 2, 2026
Posted 26.7 years ago
Arms & Interventions
Patientsother
Patients will Zollinger-Ellison Syndrome